These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23545288)

  • 1. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
    Kuo YC; Ko HF
    Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
    Kuo YC; Shih-Huang CY
    J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
    Kuo YC; Wang CC
    Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells.
    Kuo YC; Chen HH
    J Drug Target; 2010 Jul; 18(6):447-56. PubMed ID: 20528098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia.
    Kuo YC; Wang CC
    Colloids Surf B Biointerfaces; 2013 Jan; 101():101-5. PubMed ID: 22796778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
    Kuo YC; Yu HW
    Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
    Kuo YC; Su FL
    Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
    Kuo YC; Liang CT
    Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
    Kuo YC; Lee CL
    Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field.
    Kuo YC; Yu HW
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):627-34. PubMed ID: 21855303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline.
    Kuo YC; Hong TY
    Int J Pharm; 2014 Apr; 465(1-2):132-42. PubMed ID: 24524828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
    Kuo YC; Lee CH
    Life Sci; 2016 Feb; 146():222-31. PubMed ID: 26784850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
    Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
    J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
    Kuo YC; Kuo CY
    Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.
    Kuo YC; Chung CY
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):682-90. PubMed ID: 21865017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
    Kuo YC; Wang IH
    J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins.
    Kuo YC; Lu CH
    Colloids Surf B Biointerfaces; 2011 Oct; 87(1):139-45. PubMed ID: 21636258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    Kuo YC; Cheng SJ
    Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain.
    Venishetty VK; Samala R; Komuravelli R; Kuncha M; Sistla R; Diwan PV
    Nanomedicine; 2013 Apr; 9(3):388-97. PubMed ID: 22960191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.